Acute Response of Peripheral Blood Cell to Autologous Hematopoietic Stem Cell Transplantation in Type 1 Diabetic Patient

• Xiaofang Zhang ,

  Contributed equally to this work with: Xiaofang Zhang, Lei Ye

  Affiliation Shanghai Key Laboratory for Endocrine Tumors, Shanghai Clinical Center for Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Shanghai E-institute for Endocrinology, School of Medicine, Shanghai Jiaotong University, Ruijin Hospital, Shanghai, People's Republic of China

  ⨯
• Lei Ye ,

  Contributed equally to this work with: Xiaofang Zhang, Lei Ye

  Affiliation Shanghai Key Laboratory for Endocrine Tumors, Shanghai Clinical Center for Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Shanghai E-institute for Endocrinology, School of Medicine, Shanghai Jiaotong University, Ruijin Hospital, Shanghai, People's Republic of China

  ⨯
• Jiong Hu,

  Affiliation Department of Hematology, School of Medicine, Shanghai Jiaotong University, Ruijin Hospital, Shanghai, People's Republic of China

  ⨯
• Wei Tang,

  Affiliation Department of Hematology, School of Medicine, Shanghai Jiaotong University, Ruijin Hospital, Shanghai, People's Republic of China

  ⨯
• Ruixin Liu,

  Affiliation Shanghai Key Laboratory for Endocrine Tumors, Shanghai Clinical Center for Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Shanghai E-institute for Endocrinology, School of Medicine, Shanghai Jiaotong University, Ruijin Hospital, Shanghai, People's Republic of China

  ⨯
• Minglan Yang,

  Affiliation Shanghai Key Laboratory for Endocrine Tumors, Shanghai Clinical Center for Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Shanghai E-institute for Endocrinology, School of Medicine, Shanghai Jiaotong University, Ruijin Hospital, Shanghai, People's Republic of China

  ⨯
• Jie Hong,

  Affiliation Shanghai Key Laboratory for Endocrine Tumors, Shanghai Clinical Center for Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Shanghai E-institute for Endocrinology, School of Medicine, Shanghai Jiaotong University, Ruijin Hospital, Shanghai, People's Republic of China

  ⨯
• Weiqing Wang,

  Affiliation Shanghai Key Laboratory for Endocrine Tumors, Shanghai Clinical Center for Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Shanghai E-institute for Endocrinology, School of Medicine, Shanghai Jiaotong University, Ruijin Hospital, Shanghai, People's Republic of China

  ⨯
• Guang Ning,

  Affiliations Shanghai Key Laboratory for Endocrine Tumors, Shanghai Clinical Center for Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Shanghai E-institute for Endocrinology, School of Medicine, Shanghai Jiaotong University, Ruijin Hospital, Shanghai, People's Republic of China, Laboratory for Endocrine and Metabolic Diseases, Institute of Health Science, Shanghai Institutes for Biological Sciences, School of Medicine, Shanghai JiaoTong University, Chinese Academy of Sciences, Shanghai, People's Republic of China

  ⨯
• Weiqiong Gu

  * E-mail: weiqionggu@hotmail.com

  Affiliation Shanghai Key Laboratory for Endocrine Tumors, Shanghai Clinical Center for Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Shanghai E-institute for Endocrinology, School of Medicine, Shanghai Jiaotong University, Ruijin Hospital, Shanghai, People's Republic of China

  ⨯